Compare EVAX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | CNVS |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.4M | 37.7M |
| IPO Year | 2021 | 2003 |
| Metric | EVAX | CNVS |
|---|---|---|
| Price | $3.36 | $2.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.33 | $9.00 |
| AVG Volume (30 Days) | 76.2K | ★ 265.2K |
| Earning Date | 03-31-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,650,000.00 | ★ $79,791,000.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | $30.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.17 | 77.29 |
| 52 Week Low | $1.20 | $1.77 |
| 52 Week High | $12.15 | $7.39 |
| Indicator | EVAX | CNVS |
|---|---|---|
| Relative Strength Index (RSI) | 37.50 | 66.07 |
| Support Level | $3.06 | $1.77 |
| Resistance Level | $3.66 | $2.08 |
| Average True Range (ATR) | 0.33 | 0.16 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 33.26 | 98.73 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.